Clínica Las Condes S.A. (LAS-CONDES.SN)
CLP 10841.0
(-1.46%)
CLP 10841.0
(-1.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 202.26 Billion | 259.99 Billion | 276.85 Billion | 212.26 Billion | 226.19 Billion |
| Cost of Revenue | 143.11 Billion | 178.48 Billion | 203.1 Billion | 175.65 Billion | 178.24 Billion |
| Gross Profit | 59.14 Billion | 81.5 Billion | 73.74 Billion | 36.6 Billion | 47.94 Billion |
| Operating Expenses | 51.48 Billion | 54.19 Billion | 31.88 Billion | 30 Billion | 35.65 Billion |
| Selling, General and Administrative Expenses | 18.44 Billion | 26.7 Billion | 15.03 Billion | 13.11 Billion | 25.67 Billion |
| Research and Development Expenses | - | - | - | - | - |
| Other Expenses | 33.04 Billion | - | - | - | - |
| Cost and Expenses | 202.26 Billion | 232.67 Billion | 234.98 Billion | 205.66 Billion | 213.9 Billion |
| Operating Income | - | 5.96 Billion | 29.62 Billion | 1.09 Billion | 20.59 Billion |
| Interest Expense | 10.56 Billion | 9.28 Billion | 7.72 Billion | 7.11 Billion | 8 Billion |
| Income Tax Expense | -9.07 Billion | -7.36 Billion | 3.48 Billion | -4.93 Billion | 367.93 Million |
| Earnings before Tax | -12.47 Billion | -3.32 Billion | 21.89 Billion | -10.74 Billion | 5.02 Billion |
| Net Income | -3.4 Billion | 4.04 Billion | 18.41 Billion | -5.27 Billion | 5.21 Billion |
| Earnings Per Share Basic | -406.05 | 483.00 | 2199.00 | -630.36 | 623.16 |
| Earnings Per Share Diluted | -406.05 | 483.00 | 2199.00 | -630.36 | 623.16 |
| Weighted Average Shares Outstanding | 8.37 Million | 8.37 Million | 8.37 Million | 8.37 Million | 8.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.37 Million | 8.37 Million | 8.37 Million | 8.37 Million | 8.37 Million |
| Gross Margin | 0.29 | 0.31 | 0.27 | 0.17 | 0.21 |
| EBIT Margin | 0.01 | 0.03 | 0.11 | 0.01 | 0.15 |
| Profit Margin | -0.02 | 0.02 | 0.07 | -0.02 | 0.02 |
| EBITDA | 1.44 Billion | 8.48 Billion | 31.54 Billion | 2.7 Billion | 33.7 Billion |
| Earnings Before Tax Margin | - | 0.02 | 0.11 | 0.01 | 0.09 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 46.52 Billion | 47.95 Billion | 52.74 Billion | 202.26 Billion | 49.18 Billion | 48.96 Billion |
| Cost of Revenue | 31.85 Billion | 35.51 Billion | 24 Billion | 143.11 Billion | 44.14 Billion | 36.36 Billion |
| Gross Profit | 14.67 Billion | 12.44 Billion | 28.74 Billion | 59.14 Billion | 5.03 Billion | 12.6 Billion |
| Operating Expenses | 11.43 Billion | 9.83 Billion | 24.76 Billion | 51.48 Billion | 6.51 Billion | 10.57 Billion |
| Selling, General and Administrative Expenses | 4.92 Billion | 3.59 Billion | 6.69 Billion | - | 1.97 Billion | 5.19 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 6.51 Billion | - | - | - | - | - |
| Cost and Expenses | 43.28 Billion | 45.34 Billion | 48.77 Billion | 194.6 Billion | 50.66 Billion | 46.93 Billion |
| Operating Income | 1.87 Billion | -290.16 Million | 4.78 Billion | -1.9 Billion | -1.86 Billion | -438.91 Million |
| Interest Expense | 3.15 Billion | 1.41 Billion | 6.39 Billion | 10.56 Billion | 3.21 Billion | 3.07 Billion |
| Income Tax Expense | -1.23 Billion | -2.21 Billion | -1.67 Billion | -9.07 Billion | -1.56 Billion | -4.3 Billion |
| Earnings before Tax | -1.27 Billion | -1.7 Billion | -1.6 Billion | -12.47 Billion | -5.08 Billion | -3.51 Billion |
| Net Income | -44.54 Million | 513.55 Million | 70.4 Million | -3.4 Billion | -3.51 Billion | 786.67 Million |
| Earnings Per Share Basic | -5.32 | 61.00 | 8.41 | - | -419.00 | 94.00 |
| Earnings Per Share Diluted | -5.32 | 61.00 | 8.41 | - | -419.00 | 94.00 |
| Weighted Average Shares Outstanding | 8.37 Million | 8.37 Million | 8.37 Million | 8.37 Million | 8.39 Million | 8.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.37 Million | 8.37 Million | 8.37 Million | 8.37 Million | 8.39 Million | 8.36 Million |
| Gross Margin | 0.32 | 0.26 | 0.54 | 0.29 | 0.10 | 0.26 |
| EBIT Margin | 0.05 | 0.01 | 0.10 | - | -0.02 | 0.01 |
| Profit Margin | -0.00 | 0.01 | 0.00 | -0.02 | -0.07 | 0.02 |
| EBITDA | 2.46 Billion | 413.11 Million | 5.52 Billion | - | -951.86 Million | 432.8 Million |
| Earnings Before Tax Margin | 0.04 | -0.01 | 0.09 | -0.01 | -0.04 | -0.01 |
DTW
2101
300862
ACGBF
000825
1767